Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

5
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
5
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

7
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
7
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A protective role for APP in nuclear waste clearance via lysosomal exocytosis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

β-Arrestin-biased activation of type I angiotensin II receptors improves prognosis of murine pediatric heart failure.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Pathogenic Ca<sub>V</sub>1.1 Variants Cause Hyperpolarizing Shift of Depolarization-Induced Ca<sup>2+</sup> Release in Malignant Hyperthermia Susceptibility.

Communications biology·2026
Same author

Distinct brain pathways link depressive symptoms due to respiratory dysfunction and reduced physical activity in patients with chronic obstructive pulmonary disease: A single-center observational pilot study.

PloS one·2026
Same author

Loss and Gain of Aqp10 Paralogs With Broad Solute Selectivity in Anguillid Eels.

Genome biology and evolution·2025
Same author

A novel "dip-in electrode" method for electrode application to record noninvasive scalp electroencephalograms and evoked potentials in an awake common marmoset.

Neuroimage. Reports·2025
Same journal

Development of a Dedicated Prostate Phantom for Technical Evaluation of Diffusion-weighted MR Imaging Sequences.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
Same journal

Relationship between Vascular Tortuosity Rate and Atherosclerotic Risk Factors in Patients with Carotid Artery Stenosis.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
Same journal

CT- and MR Imaging-based Radiomics Approach to Differentiating Ovarian Mature and Immature Teratomas: Can MR Imaging-based Radiomics Predict the Histological Grade of Immature Teratomas?

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
Same journal

Impact of Free Water Correction on the Mean Diffusivity of Glioblastoma is Regional and b-value Dependent: A Retrospective Study on Open-source Datasets.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
Same journal

Measuring Brain Stiffness in Normal Adults According to Age and Sex Using Virtual MR Elastography: A Preliminary Study.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
Same journal

MR Imaging/Ultrasound Fusion-Guided Biopsy and Primary Focal Therapy for Localized Prostate Cancer.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

20.3K

N-acetylaspartate decrease in acute stage of ischemic stroke: a perspective from experimental and clinical studies.

Hironaka Igarashi1, Yuji Suzuki, Vincent J Huber

  • 1Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata.

Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

N-acetylaspartate (NAA) shows time-dependent attenuation reflecting brain energy metabolism during acute ischemic stroke. This metabolite serves as a unique biomarker for assessing stroke severity and guiding treatment decisions.

More Related Videos

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.7K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.5K

Related Experiment Videos

Last Updated: Apr 19, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

20.3K
Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
07:34

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

3.7K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.5K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Imaging

Background:

  • N-acetylaspartate (NAA) is a key metabolite in the brain, detectable via proton magnetic resonance spectroscopy ((1)H-MRS).
  • Acute ischemic stroke causes significant metabolic changes in the brain.
  • Current magnetic resonance (MR) imaging methods need direct metabolic biomarkers for acute stroke assessment.

Purpose of the Study:

  • To review N-acetylaspartate (NAA) metabolism.
  • To highlight the utility of NAA attenuation as a biomarker for acute ischemic stroke.
  • To emphasize the need for metabolic biomarkers in clinical decision-making for stroke.

Main Methods:

  • Review of existing literature on NAA metabolism and its role in cerebral ischemia.
  • Analysis of NAA's time-dependent attenuation patterns in the context of acute ischemic stroke.
  • Discussion of the application of (1)H-MRS for detecting NAA changes.

Main Results:

  • NAA exhibits time-dependent attenuation during acute cerebral ischemia, reflecting altered energy metabolism.
  • This attenuation pattern makes NAA a unique biomarker for assessing the acute stage of ischemic stroke.
  • (1)H-MRS can detect these metabolic shifts, offering insights into pathophysiological changes.

Conclusions:

  • NAA attenuation is a valuable indicator of metabolic dysfunction in acute ischemic stroke.
  • Utilizing NAA as a biomarker can aid in timely and accurate diagnosis and therapeutic strategies.
  • Further integration of NAA assessment in clinical practice is warranted for improved stroke management.